- Projects & figures
- News & Events
- Managing your project
- About ERC
When you think of the Renaissance period in Europe, what springs to mind? Perhaps the Medici family in Italy where the Renaissance is said to have begun, or the discovery of the ‘New World’ by Europeans like Christopher Columbus or Abel Tasman. But have you heard of the Jagiellonians?
Humans have wondered at flight since primeval times. Yet despite almost two centuries of designing machines to fly, birds still do it better in many ways. Dr Shane Windsor, a lecturer in Aerodynamics at the University of Bristol, is looking at how birds control their flight in windy conditions with the aim to improve the engineering of small-scale unmanned air vehicles (UAVs) for use in and around urban areas.
When the engines of a plane rev up and we are momentarily plunged into our seats, chances are that propulsion is due to a gas turbine. Although these energy generators are fundamental to industry, especially to aeronautics, their production of harmful exhaust gases is a cause of concern. ERC grantee Aimee Morgans works on making gas turbines greener.
Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone diseases, enabling novel therapies for hundreds of millions of people worldwide suffering from bone cancer, bacterial bone infections and osteoporosis.
Space has a wealth of resources for humanity. Scientific missions enable new discoveries and increase knowledge of our solar system. Satellites orbiting around the Earth provide us with a broad range of services for telecommunications, weather forecasting, marine and air traffic, forest mapping, etc. However, intense space activity comes at a cost both in terms of energy consumption and dangerous space debris produced.
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancer
Pancreatic cancer is the 4th leading cause of death by cancer in Europe. It has a very low survival rate with less than 1 per cent of sufferers surviving for 10 or more years. Over the last 40 years the survival rate has not significantly changed and finding an effective therapy has become a pressing challenge in cancer research. A team based at Imperial College London led by Armando Del Río Hernández, has now demonstrated that a well-known drug could be effective to fight this deadly and other forms of cancer, such as liver cancer.
Sino alla metà del XV secolo, i libri venivano scritti a mano. Nel 1455 venne stampata la Bibbia di Gutenberg, cambiando per sempre la società. Negli anni successivi milioni di libri furono stampati in tutta Europa. Cosa si sa oggi di questi libri? Chi li leggeva? Chi li acquistava? Chi li annotava? Cristina Dondi è una ricercatrice dell'Università di Oxford e curatrice della mostra "Printing Revolution 1450-1500. I 50 anni che hanno cambiato l'Europa" aperta al Museo Correr di Venezia lo scorso settembre. Forte del successo ottenuto, con oltre 90 000 visitatori a dicembre 2018, la mostra è stata prolungata sino al 30 aprile 2019. Un percorso di scoperta attraverso libri antichi e moderni strumenti digitali, frutto di anni di rigorose ricerche finanziate dall'ERC, il Consiglio europeo delle Ricerche. Sentiamo in questa intervista come nasce la passione di Cristina Dondi per i primi libri a stampa e cosa ha scoperto con le sue ultime ricerche che l'hanno portata a collaborare con biblioteche di tutto il mondo.
The inner core of our planet was discovered more than 65 years ago and since then Earth scientists have been investigating to understand more about its precise structure and geodynamic properties. Many fundamental questions still remain unanswered. Supported by the ERC, Dr Arwen Deuss has achieved some impressive results in this field.
“The next war will be fought over water, not politics,” predicted United Nations Secretary-General Boutros Boutros-Ghali in 1991. But environmental changes and pressures also have impacts that – though just as important – may be slower and more difficult to spot.
Dr Málnási-Csizmadia focuses on enzymes, proteins essential for body functions, and the largely unexplored intricate mechanisms underlying their activity. His recent findings could open the way to a ground-breaking development in pharmacology, especially in targeted cancer therapy.